Yong Ao, Changsen Leng, Junying Chen, Kongjia Luo, Lu Shao, Qianwen Liu et al. Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. // Annals of Surgical Oncology. – 2026. – DOI: 10.1245/s10434-026-20342-8. – URL: https://doi.org/10.1245/s10434-026-20342-8
Yong Ao, Changsen Leng, Junying Chen, Kongjia Luo, Lu Shao, Qianwen Liu, Qiaoqiao Li, Hui Liu, Mian Xi, Xu Zhang, Hong Yang, & Jianhua Fu (2026). Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-026-20342-8
Yong Ao, et al. “Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.” Annals of Surgical Oncology, 2026. doi:10.1245/s10434-026-20342-8.
@article{Ao2026,
title = {Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma},
author = {Ao, Yong and Leng, Changsen and Chen, Junying and Luo, Kongjia and Shao, Lu and Liu, Qianwen and Li, Qiaoqiao and Liu, Hui and Xi, Mian and Zhang, Xu and Yang, Hong and Fu, Jianhua},
journal = {Annals of Surgical Oncology},
year = {2026},
doi = {10.1245/s10434-026-20342-8},
url = {https://doi.org/10.1245/s10434-026-20342-8}
}